Is transarterial chemoembolization (TACE) evidence-based for secondary lung tumours from osteosarcoma?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18385511
Cited by: 0

Abstract

There is no direct evidence supporting the use of transarterial chemoembolization (TACE) for secondary lung tumors from osteosarcoma. Further research is needed to clarify its role in this context.

Fields of Study & Subjects

Lung Cancer Diagnosis and Treatment Sarcoma Diagnosis and Treatment Multiple and Secondary Primary Cancers

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
27 January 2026